CPC-201 Alzheimer's Disease Type Dementia: PET Study
Clinical trial NCT02860065 · WITHDRAWN
Trial details
- NCT number
- NCT02860065
- Sponsor
- Chase Pharmaceuticals Corporation, an affiliate of Allergan plc
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-30
- Primary completion
- 2017-06-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.